BEAM
Beam Therapeutics Inc
$33.74
1.21 (3.46%) Today
— up— down
Market Cap
$3.60B+100.7%
Revenue (TTM)
$163.40M+158.0%
Net Income (TTM)
$-66,018,096
$-66,018,096EPS (TTM)
-0.64
-0.64Shares Out
102.88M
102.88MOpen
$34.83
$34.83Previous Close
$34.95
$34.95Day Range
$33.74 – $35.00
$33.74 – $35.0052-Week Range
$15.60 – $36.88
$15.60 – $36.88Beta
2.22
2.22Volume
127.23K
127.23KAvg Volume
2.16M
2.16MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout BEAM
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
